Pfizer to exit GlaxoSmithKline healthcare spin-off Haleon
thetimes.co.uk
news
2022-06-01 23:01:00

The American pharmaceuticals giant Pfizer plans to offload its stake in the consumer healthcare business that is being spun out of GlaxoSmithKline after Haleon becomes a separate company next month.GSK announced yesterday that it expected that shares in Haleon, which is its joint venture with Pfizer, will be listed in the premium segment of the London Stock Exchange, making it eligible for entry into the prestigious FTSE indices, on July 18. The British drugmaker also said that Pfizer planned to sell down its stake in the company and would exit its holding 'in a disciplined manner' after the demerger.
